Kp Tissue Stock Net Income
| KPTSF Stock | USD 7.73 0.08 1.05% |
As of the 16th of February 2026, KP Tissue owns the Market Risk Adjusted Performance of (1.44), mean deviation of 0.8507, and Standard Deviation of 1.27. KP Tissue technical analysis lets you operate past data patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify KP Tissue standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if KP Tissue is priced some-what accurately, providing market reflects its prevailing price of 7.73 per share. Given that KP Tissue has jensen alpha of 0.2096, we recommend you to check KP Tissue's latest market performance to make sure the company can sustain itself sooner or later.
KP Tissue's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing KP Tissue's valuation are provided below:KP Tissue does not at this moment have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. KPTSF |
KP Tissue 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to KP Tissue's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of KP Tissue.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in KP Tissue on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding KP Tissue or generate 0.0% return on investment in KP Tissue over 90 days. KP Tissue is related to or competes with Pyxus International, Naked Wines, Naked Wines, Organto Foods, and Charlies Holdings. KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of dispo... More
KP Tissue Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure KP Tissue's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess KP Tissue upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.7 | |||
| Information Ratio | 0.1112 | |||
| Maximum Drawdown | 7.15 | |||
| Value At Risk | (2.11) | |||
| Potential Upside | 2.41 |
KP Tissue Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for KP Tissue's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as KP Tissue's standard deviation. In reality, there are many statistical measures that can use KP Tissue historical prices to predict the future KP Tissue's volatility.| Risk Adjusted Performance | 0.1378 | |||
| Jensen Alpha | 0.2096 | |||
| Total Risk Alpha | 0.1069 | |||
| Sortino Ratio | 0.0831 | |||
| Treynor Ratio | (1.45) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of KP Tissue's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
KP Tissue February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1378 | |||
| Market Risk Adjusted Performance | (1.44) | |||
| Mean Deviation | 0.8507 | |||
| Semi Deviation | 0.7883 | |||
| Downside Deviation | 1.7 | |||
| Coefficient Of Variation | 601.46 | |||
| Standard Deviation | 1.27 | |||
| Variance | 1.62 | |||
| Information Ratio | 0.1112 | |||
| Jensen Alpha | 0.2096 | |||
| Total Risk Alpha | 0.1069 | |||
| Sortino Ratio | 0.0831 | |||
| Treynor Ratio | (1.45) | |||
| Maximum Drawdown | 7.15 | |||
| Value At Risk | (2.11) | |||
| Potential Upside | 2.41 | |||
| Downside Variance | 2.9 | |||
| Semi Variance | 0.6214 | |||
| Expected Short fall | (1.48) | |||
| Skewness | 0.1873 | |||
| Kurtosis | 1.59 |
KP Tissue Backtested Returns
KP Tissue appears to be not too volatile, given 3 months investment horizon. KP Tissue retains Efficiency (Sharpe Ratio) of 0.17, which conveys that the firm had a 0.17 % return per unit of price deviation over the last 3 months. We have found twenty-seven technical indicators for KP Tissue, which you can use to evaluate the volatility of the firm. Please exercise KP Tissue's Standard Deviation of 1.27, mean deviation of 0.8507, and Market Risk Adjusted Performance of (1.44) to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, KP Tissue holds a performance score of 13. The company owns a Beta (Systematic Risk) of -0.14, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning KP Tissue are expected to decrease at a much lower rate. During the bear market, KP Tissue is likely to outperform the market. Please check KP Tissue's maximum drawdown, and the relationship between the information ratio and expected short fall , to make a quick decision on whether KP Tissue's current price history will revert.
Auto-correlation | -0.42 |
Modest reverse predictability
KP Tissue has modest reverse predictability. Overlapping area represents the amount of predictability between KP Tissue time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of KP Tissue price movement. The serial correlation of -0.42 indicates that just about 42.0% of current KP Tissue price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.42 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, KP Tissue reported net income of 1.24 M. This is 99.89% lower than that of the Household Products sector and 99.88% lower than that of the Consumer Staples industry. The net income for all United States stocks is 99.78% higher than that of the company.
KPTSF Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses KP Tissue's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of KP Tissue could also be used in its relative valuation, which is a method of valuing KP Tissue by comparing valuation metrics of similar companies.KP Tissue is currently under evaluation in net income category among its peers.
KPTSF Fundamentals
| Return On Equity | -0.0716 | |||
| Current Valuation | 74.38 M | |||
| Shares Outstanding | 9.94 M | |||
| Shares Owned By Insiders | 0.07 % | |||
| Shares Owned By Institutions | 18.82 % | |||
| Price To Earning | 85.11 X | |||
| Price To Book | 1.24 X | |||
| Net Income | 1.24 M | |||
| Current Ratio | 1.24 X | |||
| Book Value Per Share | 8.43 X | |||
| Earnings Per Share | 0.09 X | |||
| Number Of Employees | 16 | |||
| Beta | 0.59 | |||
| Market Capitalization | 76.14 M | |||
| Total Asset | 80.72 M | |||
| Annual Yield | 0.07 % | |||
| Net Asset | 80.72 M | |||
| Last Dividend Paid | 0.72 |
About KP Tissue Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze KP Tissue's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of KP Tissue using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of KP Tissue based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in KPTSF Pink Sheet
KP Tissue financial ratios help investors to determine whether KPTSF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KPTSF with respect to the benefits of owning KP Tissue security.